Price $2.71 |
Market Cap
15.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.33
|
P/S
2.46
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-12.7K
|
FCF
-2.1
|
|
Op. Margin
-
|
Net Margin
-203.10%
|
ROE
-25.70%
|
ROI
-16.10%
|
|
ROA
-18.30%
|
EPS Growth
-74.10%
|
Current Ratio
9.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc (AMRX) | $1.31 | - | - | 604.1M | Strong Buy |
| Akumin Inc (AKU) | $0.70 | - | - | 108.7M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $1.26 | - | - | 129.6M | Strong Buy |
| Akebia Therapeutics Inc (AKBA) | $0.61 | - | - | 171M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $8.84 | - | - | 11.23B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
